Small Bowel Anastomosis

Pipeline Programs

Companies

Clinical Trials

Approved Products

Pipeline by Development Stage

Preclinical

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

On Market

Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Pre

P1/2

P2/3

Mkt

GI WindowsMA - Westwood

2 programs

Small Bowel AnastomosisN/A1 trial

Small Bowel Anastomosis with Flexagon SFM Device with OTOLocN/A1 trial

Active Trials

NCT07695558Not Yet Recruiting70Est. Jun 2028

NCT06454916Completed79Est. Oct 2025

Trial Timeline

Clinical trial activity over time

2024

2025

2026

2027

2028

GI WindowsSmall Bowel Anastomosis

GI WindowsSmall Bowel Anastomosis with Flexagon SFM Device with OTOLoc

Clinical Trials (2)

Total enrollment: 149 patients across 2 trials

NCT07695558 GI WindowsSmall Bowel Anastomosis

Post Market Study of the Flexagon Only System and Flexagon Plus OTOLoc for Creation of Side-to-Side Duodeno-Ileal Diversion & Flexagon Plus OTOLoc Self Forming Magnet (SFM) System for Creation of Side-to-Side Jejunum-Jejunum and Ileal-Ileal Anastomoses

Start: Jul 2026Est. completion: Jun 202870 patients

N/ANot Yet Recruiting

NCT06454916 GI WindowsSmall Bowel Anastomosis with Flexagon SFM Device with OTOLoc

Functional Lumen Opening With Self-Forming Magnetic Anastomosis

Start: Oct 2024Est. completion: Oct 202579 patients

N/ACompleted

Phase Legend

Preclinical— Lab & animal studies

Phase 1— Safety & dosing

Phase 2— Efficacy testing

Phase 3— Large-scale trials

On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.